(Q43061745)

13 November 2017

title

Structure-based and ligand-based drug design for HER 2 receptor (English)

1 reference

13 November 2017

Hung-Jin Huang

1

1 reference

13 November 2017

Kuei-Jen Lee

2

1 reference

13 November 2017

Hsin W Yu

3

1 reference

13 November 2017

Chien-Yu Chen

4

1 reference

13 November 2017

Chih-Ho Hsu

5

1 reference

13 November 2017

Hsin-Yi Chen

6

1 reference

13 November 2017

Fuu-Jen Tsai

7

1 reference

13 November 2017

Calvin Yu-Chian Chen

8

1 reference

13 November 2017

language of work or name

1 reference

1 August 2010

1 reference

Journal of Biomolecular Structure and Dynamics

13 November 2017

published in

1 reference

13 November 2017

volume

28

1 reference

13 November 2017

issue

1

1 reference

13 November 2017

page(s)

23-37

1 reference

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

13 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2010.10507341

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2010.10507341

HER-2/neu oncogene protein and prognosis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2010.10507341

Down-regulation of myeloid cell leukemia-1 through inhibiting Erk/Pin 1 pathway by sorafenib facilitates chemosensitization in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2010.10507341

Functional genomic analysis identified epidermal growth factor receptor activation as the most common genetic event in oral squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2010.10507341

Correlation of intrinsic chemoresistance of non-small-cell lung cancer cell lines with HER-2/neu gene expression but not with ras gene mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2010.10507341

Design, synthesis, and docking studies of peptidomimetics based on HER2-herceptin binding site with potential antiproliferative activity against breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2010.10507341

Tyrosine kinase activation in the decision between growth, differentiation, and death responses initiated from the B cell antigen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2010.10507341

Increase in hepatocyte growth factor receptor tyrosine kinase activity in renal carcinoma cells is associated with increased motility partly through phosphoinositide 3-kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2010.10507341

HER2/neu in systemic therapy for women with breast cancer: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2010.10507341

Current paradigms for the use of HER2-targeted therapy in early-stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2010.10507341

Benefit in lung function improvement and side-effect profile of long-term responders: an analysis of 14 NSCLC patients treated for at least 9 months with gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2010.10507341

Tyrosine kinase inhibitors - a review on pharmacology, metabolism and side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2010.10507341

Computer-aided drug design of novel PLA2 inhibitor candidates for treatment of snakebite

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2010.10507341

Computational anti-AIDS drug design based on the analysis of the specific interactions between immunophilins and the HIV-1 gp120 V3 loop. Application to the FK506-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2010.10507341

Molecular modeling studies of the interaction between Plasmodium falciparum HslU and HslV subunits

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2010.10507341

Molecular dynamics simulations to gain insights into the stability and morphologies of K3 oligomers from beta2-microglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2010.10507341

Molecular dynamics simulations to investigate the aggregation behaviors of the Abeta(17-42) oligomers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2010.10507341

An insight to the dynamics of conserved water molecular triad in IMPDH II (human): recognition of cofactor and substrate to catalytic Arg 322.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2010.10507341

Molecular dynamics simulations to investigate the structural stability and aggregation behavior of the GGVVIA oligomers derived from amyloid beta peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2010.10507341

Conformational dynamics of human AP endonuclease in base excision and nucleotide incision repair pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2010.10507341

Disruption mechanism in the helix of SPF peptide by interchanging E5 and K10 residues: inference from molecular dynamics study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2010.10507341

Weighted equation and rules--a novel concept for evaluating protein-ligand interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2010.10507341

Computational screening and design of traditional Chinese medicine (TCM) to block phosphodiesterase-5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2010.10507341

Discovery of potent inhibitors for phosphodiesterase 5 by virtual screening and pharmacophore analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2010.10507341

Ligand-based dual target drug design for H1N1: swine flu--a preliminary first study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2010.10507341

Puerariae radix isoflavones and their metabolites inhibit growth and induce apoptosis in breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2010.10507341

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2010.10507341

A novel perspective on designing the inhibitor of HER2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2010.10507341

10.1080/07391102.2010.10507341

21 January 2018

Identifiers

DOI

1 reference

13 November 2017

1 reference